{"name":"Chemi S.p.A.","slug":"chemi-s-p-a","ticker":"","exchange":"","domain":"","description":"Chemi S.p.A. is an Italian pharmaceutical company focused on the development of innovative treatments in the early stages of clinical trials. The company has a pipeline of three drugs, all currently in Phase 2, with a focus on advanced delivery mechanisms and novel formulations.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQSnczWWhJT21nSWw3ZFFWMGsyU0c2Mm51MHNSZkVSYThpZWtRWmZSbkc1X3JpQng2RThtTUJuNGVzSjlBZTdjdlFDWWk3RFJoRlJhTXQ1el9ERGprNlJrSmhuOU9LdXlxNzZhVnZrWEhZWXd0VF9OUTNveTBTVlhQQlNpVmlLR0xqNlF6TjAxWU16TTlDRkdJVl9NSmQ4UFNjNnhuc3BZZWpQYUcxck43NnVYTUlESGhnb29GNmhpdjZrbWYwcHNFN2ZVeG53LVl2Zk04cjJCX2Q4NC1sUU1B?oc=5","date":"2026-02-06","type":"pipeline","source":"NutraIngredients.com","summary":"US manufacturing access opens new Alpha-GPC format options in maturing cognitive health market - NutraIngredients.com","headline":"US manufacturing access opens new Alpha-GPC format options in maturing cognitive health market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQX3RkbUlYYXFIMmYtcHhyLTVzcEdWRWRJTkZGNnFrWTVtRTZPSUZqbG9tQkRiME9iYkpDV1RuLUVIRmhOT0ZUeUdFUGludndkcm55V0o0OG9VS29ZeWhwd1BreUUwWWFDcDRnd1FmWk5EVkg5QUV2SlZaNlpfeVljc0RlQzlQQ2F3MVNfVVNsQ1FuUEQ4U0RvZjJqY29TdjJfV0MwcWlGWkJFTEdSZzJpNUZTUXE?oc=5","date":"2025-11-07","type":"pipeline","source":"Zee Business","summary":"Torrent Pharma's open offer for JB Chem—Price, date, other key details - Zee Business","headline":"Torrent Pharma's open offer for JB Chem—Price, date, other key details","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-30","type":"deal","source":"Business Standard","summary":"Torrent Pharma share pops 4% on ₹25,689-cr JB Chem deal; analysts cautious - Business Standard","headline":"Torrent Pharma share pops 4% on ₹25,689-cr JB Chem deal; analysts cautious","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-05-09","type":"regulatory","source":"ET Pharma","summary":"Zydus Multiple Sclerosis generic receives FDA final nod - ET Pharma","headline":"Zydus Multiple Sclerosis generic receives FDA final nod","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-05-09","type":"regulatory","source":"The Economic Times","summary":"Zydus gets USFDA nod for generic drug to treat multiple sclerosis - The Economic Times","headline":"Zydus gets USFDA nod for generic drug to treat multiple sclerosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxNUXZMN2lvUEQ0TW9ZX3NqRVV3dlcxa0s5c2Rxal9ubUhuZzZsQzhPeVFYUHUtVnhTSmk2eGdjMU9GUmxKNUMwTzJfRGN1ejA3MTBNWG0ycWhudGs3cndlamxTM1k1R2NjSllmVzZQVk1KbGctSkVuZzVMU19mWGJSMzdvdnAwWVJPdEZ6Nk5oTWVRbDRBVGdxTFkxM2dGYjdja2hmNnFvVzNCaWUwbkZfd0plTmJmS0sxSEc2X21ZOU5kcFU0ajhxb1F5R1c5LUE4ZFR5RW5qQVhJVUhRb3g5U0JoU29ZVFVKdS04SUN3eFFUWWJHSmt1b2hRSnE2NU05dzVmRE1rUEN4TmktbmNOV3VhTWNQcFlLM2c0WXNZTGZkbzlaR2lCbThPVGlkS21hRlFz?oc=5","date":"2025-05-08","type":"regulatory","source":"Business Wire","summary":"Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes - Business Wire","headline":"Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxObVFFYkFsY0dJYTN2UGEtUHlVdi1HQ3NiRHVJX2ZrSXlhNXVQRFlTbm9ZNzRpQUFFUlhMNHROOFBFTHlnVnZ0aEpzWjRsUnYtQ004NnFVM3ZHR3M0M3pWdVhreU5YeDJVbjA4bFNrbjM1ZEZvRUNDZjRLU19aM04yR25feXptbGVPMW9v?oc=5","date":"2024-09-12","type":"pipeline","source":"SupplySide Supplement Journal","summary":"Chemi Nutra ~ AlphaSize 60F A-GPC - SupplySide Supplement Journal","headline":"Chemi Nutra ~ AlphaSize 60F A-GPC","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-09-22","type":"pipeline","source":"Medical Dialogues","summary":"Zydus Cadila arm to sell 2 brands Mifegest, Cytolog to Integrace - Medical Dialogues","headline":"Zydus Cadila arm to sell 2 brands Mifegest, Cytolog to Integrace","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-08-20","type":"patent","source":"The Economic Times","summary":"Cadila inks pact with Italian firm to launch generic product in US - The Economic Times","headline":"Cadila inks pact with Italian firm to launch generic product in US","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}